Conclusions: Popliteal venous aneurysm is a rare cause of pulmonary embolism. Surgical resection and revascularization are recommended to treat popliteal venous aneurysm for prevention of venous thromboembolism and pulmonary embolism.
IP257. Endovascular Salvage of Early Distal Splenorenal Shunt Occlusion With Resultant Long-term Patency
Eric Gandras, Kan Chen, Greg Goldstein, Juan Madariaga, Kambhampaty Krishnasastry, Craig Greben. Northwell Health System, New York, NY Objectives: Distal splenorenal shunt (DSRS) is a treatment option for variceal bleeding caused by portal hypertension when a transjugular intrahepatic portosystemic shunt is not an option. Failure of DSRS in the postoperative period has been reported to occur in 5% to 11% of patients. To our knowledge, there have not been any reports describing successful, durable percutaneous revascularization of a completely occluded DSRS in the early postoperative period. We describe the feasibility and long-term success of endovascular salvage of early DSRS occlusion in a young patient with congenital portal vein thrombosis.
Methods: A 19-year-old man with congenital portal vein thrombosis complicated by esophageal varices presented with massive gastric variceal bleeding treated with emergent balloon tamponade and gastrotomy with variceal ligation. Computed tomography (CT) angiography revealed chronic portal vein thrombosis with cavernous transformation, found to be secondary to a congenital hypercoagulable state (hyperhomocysteinemia with MTHFR mutation). DSRS was performed electively 5 months later for recurrent nonmassive hemorrhage. The patient developed worsening ascites and a CT performed 8 days postoperatively suggested DSRS thrombosis, which led to referral. Via a right femoral vein approach, the expected location of the shunt at the left adrenal vein was probed with a 2.8F microcatheter and microwire via a 5F catheter. The shunt anastomosis was crossed with a venogram revealing a severe anastomotic stenosis in the splenic vein (Fig, A) . The system was exchanged for a 5F sheath, and via the sheath, a 5-mm Â 18-mm stent was deployed across the anastomotic stenosis. Poststent images demonstrated an improved caliber and flow but a small amount of nonocclusive residual thrombus within the shunt. Suction thrombectomy was performed via the guiding sheath. Post-treatment images demonstrated restored patency with resolution of thrombus and draining of the splenic vein into the left renal vein (Fig, B) .
Results: Follow-up cross-sectional imaging with duplex ultrasound and contrast-enhanced CT at 36 months demonstrated shunt patency. No episodes of hemorrhage have occurred since shunt revascularization.
Conclusions: Our report demonstrates the feasibility of endovascular salvage of early postoperative occlusion of DSRS with documented long term clinical success and shunt patency.
Author Disclosures: K. Chen: Nothing to disclose; E. Gandras: Vascular Solutions: royalties, intellectual property/patents, and consulting fees (eg, advisory boards); G. Goldstein: Nothing to disclose; C. Greben: Nothing to disclose; K. Krishnasastry: Nothing to disclose; J. Madariaga: Nothing to disclose. Objectives: Symptomatic relief after endovenous thermal ablation (EVTA) is incomplete in some patients after the ablative procedure despite closure of the insufficient saphenous vein and associated varicosities. In past patients who had undergone vein stents for chronic proximal venous outflow obstruction (PVOO), we have observed some patients had a history of varicose veins and prior EVTA. This study was undertaken to establish a better understanding of patients with chronic PVOO and superficial venous disease.
IP259. Persistent Symptoms After Endovenous Thermal
Methods: .Medical records of 484 patients who underwent vein stent placement for chronic PVOO from 2013 to 2016 were retrospectively reviewed; of these, 78 patients had EVTA prior to vein stenting and met inclusion criteria: persistent venous disease symptoms, of which edema was the primary symptom, prior EVTA of the saphenous vein, a venous duplex scan that confirmed the closure of superficial veins from prior EVTA, and PVOO in the iliac vein as suggested by a computed tomography or magnetic resonance venogram. Vein stent outcome was determined by patient report and clinical assessment. Wilcoxon-Mann-Whitney tests were performed for categoric variables. Additionally, Kruskal-Wallis tests were run for ordinal variables, as well as logistic regressions for outcomes at 30 days, 90 days, 6 months, and 1 year postoperation.
Results: Of 78 patients (48 females [61.5%]), average age was 59.7 years, and median follow-up time was 352 days. There was no significant difference in outcome between CEAP classes or in the number of stents placed based on Kruskal-Wallis. The Table reports the outcome after vein stents at 30 days, 90 days, 6 months, and 1 year. Thirty-eight (48.7%) reported major improvement at 30 days, 39 (50%) reported major improvement, and 14 (18%) felt complete relief by 90 days. WilcoxonMann-Whitney tests were significant for major improvement among patients with prestent edema after EVTA at 30 (P ¼ .022) and 90 days (P ¼ .026). Ordered logistic regressions also found that the presence of edema could predict increased improvement at 30 (95% confidence interval, 0.57-7.22; P ¼ .022) and 90 days (95% confidence interval, 0.03-6.18; P ¼ .048).While 45.5% felt major improvement and 22.3% felt complete relief at 6 months, and 47.9% felt major improvement and 22.3% felt normal at 1 year, these values were not statistically significant.
Conclusions: Superficial venous disease and PVOO may coexist, and both may contribute to venous symptoms. Persistent symptoms after EVTA suggest possible presence of concurrent PVOO, and evaluation should be considered. If diagnosis is confirmed, venous stenting in persistently symptomatic patients after EVTA appears to be a safe and potential way to effectively further improve symptoms in early postoperative period.
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IP261.

Success Rate and Predictive Factors for Redo Radiofrequency Ablation of Perforator Veins
Methods: A retrospective analysis of 642 procedures in 256 patients with venous insufficiency due to IPVs treated with RFA from 2009 to 2015 was conducted. A redo ablation was done in 52 IPVs (28 patients), including 13 women, with mean (standard deviation) age of 65 6 15 years. The patients had presenting symptoms of CEAP: 0, C 1 ; 0, C 2 ; 5, C 3 ; 13, C 4a ; 9, C 4b ; 0, C 5 ; and 25, C 6 . The 52 IPVs were distributed in the calf (40) and 
